InProTher is looking for a Director of Operations and Finance
If you are interested in knowing more about this position please follow the link below: Now Hiring: Director of Operations and Finance
InProTher announces the appointment of Jordi Naval as CEO, along with angel investment funding
Copenhagen, February 15th 2021 InProTher Aps, a biotechnology company focused on developing breakthrough strategies for Immuno-oncology based on a new target class of endogenous retroviruses, today announced that it has appointed Jordi Naval as chief…
Dr. Martin Gleave joins InProTher as scientific advisor
InProTher is pleased to announce a new, exciting collaboration with Dr. Martin Gleave who joins the company as a scientific advisor. Dr. Gleave is a urologic surgeon and Distinguished Professor and Chair of the Department…
Postdoctoral grant allows InProTher to engage in new exciting collaborations
Following the recruitment of Emeline Ragonnaud, who joined the team from NIH in June this year, InProTher is now delighted to announce the award of a postdoctoral grant from Innovation Fund Denmark for her project. …
InProTher attracts profile from NIH: Emeline Ragonnaud reunites with Peter J. Holst after 3 years
After spending 3 years in the US as a postdoctoral fellow at the National Institutes of Health (NIH), 32-year-old Emeline Ragonnaud has now moved to Denmark and joined InProTher. But apart from being a story…
A family of research superstars: InProTher’s founder is carrying on an impressive legacy
“I was in our sailboat with my dad. I think I was 8 or 9 years old. I asked him if anything exciting happened recently. He said he had discovered a new hormone which was…
CEO at SIRION, Christian Thirion, joins InProTher as a Board Member
InProTher is pleased to welcome Christian O. Thirion, Ph.D., who has joined the Board of Directors in February 2020. Christian is the founder and CEO of SIRION Biotech GmbH, a company that InProTher recently entered…
Former F-star CEO joins InProTher as strategic advisor
InProTher can proudly welcome John Haurum, M.D., Ph.D. as a strategic advisor. John Haurum is a Non-executive Director in various European biotech companies, i.e. Synklino, Neophore, and Synact. From 2012 – 2018, Haurum was the…
SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)
MUNICH & COPENHAGEN, February 4, 2020— SIRION Biotech GmbH (“SIRION”), a world leader in viral vector-based gene delivery technologies for gene and cell therapy, and InProTher Aps (“InProTher”), a Danish start up supported by Novo…
Peter J. Holst to step in as interim CEO, Mathias Kroll to continue as an Advisory Board Member
After joining InProTher as the CEO in June 2019, Mathias Kroll has now decided to step down. It is not a goodbye, though, as he will continue as a strong player on the Advisory Board….